These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

577 related articles for article (PubMed ID: 32325980)

  • 21. Prioritizing zoonotic diseases using a multisectoral, One Health approach for The Economic Community of West African States (ECOWAS).
    Goryoka GW; Lokossou VK; Varela K; Oussayef N; Kofi B; Iwar V; Behravesh CB
    One Health Outlook; 2021 Nov; 3(1):24. PubMed ID: 34809700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Global threats from emerging viral diseases].
    Chastel C
    Bull Acad Natl Med; 2007 Nov; 191(8):1563-77. PubMed ID: 18666456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serological evidence of Flavivirus circulation in human populations in Northern Kenya: an assessment of disease risk 2016-2017.
    Chepkorir E; Tchouassi DP; Konongoi SL; Lutomiah J; Tigoi C; Irura Z; Eyase F; Venter M; Sang R
    Virol J; 2019 May; 16(1):65. PubMed ID: 31101058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Four human diseases with significant public health impact caused by mosquito-borne flaviviruses: West Nile, Zika, dengue and yellow fever.
    Guarner J; Hale GL
    Semin Diagn Pathol; 2019 May; 36(3):170-176. PubMed ID: 31006554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of Nonfoodborne Zoonotic and Potentially Zoonotic Poultry Diseases.
    Agunos A; Pierson FW; Lungu B; Dunn PA; Tablante N
    Avian Dis; 2016 Sep; 60(3):553-75. PubMed ID: 27610715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of antiviral peptides for use against zoonotic and selected non-zoonotic viruses.
    Hollmann A; Cardoso NP; Espeche JC; Maffía PC
    Peptides; 2021 Aug; 142():170570. PubMed ID: 34000327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emerging arboviruses of medical importance in the Mediterranean region.
    Papa A
    J Clin Virol; 2019 Jun; 115():5-10. PubMed ID: 30928817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A systematic review to describe patterns of animal and human viral research in Rwanda.
    Dutuze MF; Byukusenge M; Shyaka A; Christofferson RC
    Int Health; 2023 Mar; 15(2):113-122. PubMed ID: 35650601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiological processes involved in the emergence of vector-borne diseases: West Nile fever, Rift Valley fever, Japanese encephalitis and Crimean-Congo haemorrhagic fever.
    Chevalier V; de la Rocque S; Baldet T; Vial L; Roger F
    Rev Sci Tech; 2004 Aug; 23(2):535-55. PubMed ID: 15702718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rift Valley fever virus.
    Flick R; Bouloy M
    Curr Mol Med; 2005 Dec; 5(8):827-34. PubMed ID: 16375716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rift Valley Fever: An Emerging Mosquito-Borne Disease.
    Linthicum KJ; Britch SC; Anyamba A
    Annu Rev Entomol; 2016; 61():395-415. PubMed ID: 26982443
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A perspective on targeting non-structural proteins to combat neglected tropical diseases: Dengue, West Nile and Chikungunya viruses.
    Bhakat S; Karubiu W; Jayaprakash V; Soliman ME
    Eur J Med Chem; 2014 Nov; 87():677-702. PubMed ID: 25305334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Translating Predictions of Zoonotic Viruses for Policymakers.
    Judson SD; LeBreton M; Fuller T; Hoffman RM; Njabo K; Brewer TF; Dibongue E; Diffo J; Kameni JF; Loul S; Nchinda GW; Njouom R; Nwobegahay J; Takuo JM; Torimiro JN; Wade A; Smith TB
    Ecohealth; 2018 Mar; 15(1):52-62. PubMed ID: 29230614
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zika, Chikungunya, and Other Emerging Vector-Borne Viral Diseases.
    Weaver SC; Charlier C; Vasilakis N; Lecuit M
    Annu Rev Med; 2018 Jan; 69():395-408. PubMed ID: 28846489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging vector-borne zoonoses: eco-epidemiology and public health implications in India.
    Dhiman RC
    Front Public Health; 2014; 2():168. PubMed ID: 25325052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Emerging viral threats in Gabon: health capacities and response to the risk of emerging zoonotic diseases in Central Africa.
    Bourgarel M; Wauquier N; Gonzalez JP
    Emerg Health Threats J; 2010; 3():e7. PubMed ID: 22460397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of zoonotic disease surveillance supported by the Armed Forces Health Surveillance Center.
    Burke RL; Kronmann KC; Daniels CC; Meyers M; Byarugaba DK; Dueger E; Klein TA; Evans BP; Vest KG
    Zoonoses Public Health; 2012 May; 59(3):164-75. PubMed ID: 22128834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe.
    Mansfield KL; Banyard AC; McElhinney L; Johnson N; Horton DL; Hernández-Triana LM; Fooks AR
    Vaccine; 2015 Oct; 33(42):5520-5531. PubMed ID: 26296499
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease and destiny-mystery and mastery.
    Beran GW
    Prev Vet Med; 2008 Sep; 86(3-4):198-207. PubMed ID: 18639356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential Benefits of Antiviral African Medicinal Plants in the Management of Viral Infections: Systematic Review.
    Beressa TB; Deyno S; Mtewa AG; Aidah N; Tuyiringire N; Lukubye B; Weisheit A; Tolo CU; Ogwang PE
    Front Pharmacol; 2021; 12():682794. PubMed ID: 35002686
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.